Compare ATYR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | NREF |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 296.5M |
| IPO Year | 2015 | N/A |
| Metric | ATYR | NREF |
|---|---|---|
| Price | $0.43 | $17.32 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $3.67 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 605.1K | 36.3K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 13.95% |
| EPS Growth | ★ 6.98 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $190,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.47 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $12.36 |
| 52 Week High | $6.50 | $18.43 |
| Indicator | ATYR | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 34.21 | 51.07 |
| Support Level | $0.40 | $16.39 |
| Resistance Level | $0.59 | $18.27 |
| Average True Range (ATR) | 0.04 | 0.41 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 0.14 | 30.98 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.